Research Interests:
The research interests of the Fungus Testing Laboratory encompass two broad arms. The first area of interest includes the evaluation of antifungal agents. These activities include both the in vitro susceptibility testing of a wide range of clinically-significant fungi against approved, investigational, orphan, and potential antifungal drugs/compounds, as well as the development of and providing assays for antifungal drugs in body fluids of patients receiving antifungal therapy. The Fungus Testing Laboratory is a national reference site for the testing of antifungal agents, and is an appointed site location for the Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards. A component of our involvement with antifungal agents also includes the design of and participation in various clinical trials relative to either the investigational compounds, or studies regarding new indications for approved agents. The second arm of our research involves being actively engaged in promoting accurate taxonomy, nomenclature, and classification of pathogenic fungi. As a repository for clinical isolates from across the nation and abroad, we constantly monitor the appearance of new etiologic agents, provide reports of these findings via abstracts/manuscripts, and update clinical laboratories regarding these new agents through several invited teaching workshops.

Unique Technical and Clinical Research Capabilities/Instrumentation:
The Fungus Testing Laboratory serves as an international reference laboratory for the identification of fungal isolates to the species level, provides in vitro susceptibility testing of both yeasts and moulds, including dimorphic pathogens, and determines antifungal drug levels in body fluids by bioassay, HPLC, and GLC methodologies. Additionally, we serve as a cite laboratory for clinical trials of various approved/investigational antifungal agents. This laboratory is also a federally approved Select Agent site for the maintenance and testing of Coccidioides immitis isolates.



  • Sutton, D.A., A.W. Fothergill, and M.G. Rinaldi. 1998.  Guide to Clinically Significant Fungi.  Williams and Wilkins, Baltimore, MD

Book chapters:

  • Fothergill, A.W., and D.A. McGough.  1992.  In vitro Antifungal Susceptibility Testing of Yeasts: Macro-broth Dilution Technique.  A chapter in ASM Clinical Microbiology Procedures Handbook, 5.15.1 – 5.15.16, Isenberg, H. (ed.), American Society for Microbiology.
  • McGough, D.A., A.W. Fothergill, M.G. Rinaldi, and M.A. Pfaller.  1994.  Fungi and fungal infections.  Chapter 45 In: Clinical Laboratory Medicine.  McClatchey, K.E.(ed.) Williams and Wilkins, Baltimore, MD.
  • McGough, D.A., A.W. Fothergill, L. Smith, and A. Romo.  1995.  Medically Significant Fungi.  Chapter 23.  In: Textbook of Diagnostic Microbiology.  Manuselis, G., Mahon, C. (eds.), W.B. Saunders Company, Philadelphia, PA.
  • Smith, L., A.W. Fothergill, D.A. Sutton, and J. Harris.  2000.  Medically Significant Fungi.  Chapter 23. In: Textbook of Diagnostic Microbiology, 2nd edition, Manuselis, G., Mahon, C. (eds.), W.B. Saunders Company, Philadelphia, PA.
  • Pacheco, P., D.A. Sutton, and M.G. Rinaldi.  2000.  Phaeohyphomycosis and hyalohyphomycosis.  Chapter 15.  In: Fungal Infections, Volume XII, Atlas of Infectious Diseases. R. Diamond (ed.), Current Medicine, Philadelphia, PA.
  • Mujeeb, I., D.A. Sutton, A.W. Fothergill, M.G. Rinaldi, and M.A. Pfaller.  2002.   Fungi and fungal infections.  Chapter 52 In: Clinical Laboratory Medicine, 2nd edition.  Lippincott Williams & Wilkins, Philadelphia, PA.
  • Rinaldi, M.G., S.A. Sanche, D.A. Sutton, and M.G. McGinnis.  2002.  Dematiaceous Fungi.  Chapter 14 In: Clinical Mycology.  E. Anaissie, M. McGinnis, M. Pfaller (eds.), Saunders, Philadelphia, PA.
  • Sutton, D.A.  2003.  Specimen Collection, Transport, and Processing:  Mycology.  Chapter 111 In: ASM Manual of Clinical Microbiology, 8th edition, ASM Press, Washington, DC.
  • Sutton, D.A.  2007.  Specimen Collection, Transport, and Processing:  Mycology.  Chapter 116 InASM Manual of Clinical Microbiology, 9th edition, ASM Press, Washington, DC
  • Sutton, D.A.  2007.  Basic Mycology.  Chapter 2 InDiagnosis and Treatment of Human Mycoses.    D.R. Hospenthal, M.G. Rinaldi (eds.) , The Humana Press Inc., Totowa, NJ.,
  • Sutton, D.A. andT.F. Patterson.  2008.  Malassezia species. Chapter 248 In Principles and Practice of Pediatric Infectious Diseases, 3rd Edition.  S.S. Long, L.K. Pickering, CG Prober  (eds.), Elsevier Science, Philadelphia, PA.
  • Sutton, D.A, M.G. Rinaldi, and S.E. Sanche.  2008.  Dematiaceous Fungi In: Clinical Mycology, 2nd ed (Anaissie, McGinnis, Pfaller, eds), Elsevier, UK.


  • Koneman, E., D.A. Sutton, A.W. Fothergill, M.G. Rinaldi, T. Sun, and S.F. Straus. 2001 . LWW’s Organism Central, Lippincott Williams & Wilkins, Hagerstown, MD.

Referred Papers:

  • Schwartz JG,  McGough DA,  Thorner RE,  Fetchick  RJ,  Tio FO,  Rinaldi MG.  1988. Primary lymphocutaneous Nocardia brasiliensis infection: three case reports and a review of the literature.  Diag Microbiol Infect Dis 10:113-120.
  • McGough DA, Fothergill AW, Rinaldi MG.  1990.  Cokeromyces recurvatus Poitras: a distinctive zygomycete and potential pathogen.  Criteria for identfication. Clin Microbiol Newsletter 12:113-117.
  • Walsh TJ, Melcher GP, Rinaldi MG. Lecciones J, McGough D, Lee J, Callender D, Rubin M, Pizzo PA.   1990.  Disseminated trichosporonosis resistant to amphotericin B.  J Clin Microbiol 28:1616-1622.
  • Bourbeau P, McGough DA, Fraser H, Shah N, Rinaldi, MG.  1992.  Fatal disseminated infection caused by Myceliophthora thermophila, a new agent of mycosis; case history and laboratory characteristics.  J Clin Microbiol 30:3019-3023.
  • Melcher GP, McGough DA, Fothergill AW, Norris C, Rinaldi MG.  1993.   Disseminated hyalohyphomycosis caused by a novel human pathogen: Fusarium napiforme.  J Clin Microbiol 31:1461-1467.
  • McGough DA.  1993.  Clinical and laboratory aspects of the “black yeasts”.  Clin Microbiol Newsletter 15:145-151.
  • Colombo AL, McGough DA, Rinaldi MG.  1994.  Discrepancies between MIC and MLC values for amphotericin B against isolates of Aspergillus species.  Mycopathologia 128:129-133.
  • Barchiesi F, Colombo AL, McGough DA, Fothergill AW, Rinaldi MG.  1994.  In vitro activity of itraconazole against fluconazole-susceptible and –resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus.  Antimicrob Agents Chemother 38:2553-2556.
  • Barchiesi F, Colombo AL, McGough DA, Fothergill AW, Rinaldi MG.  1994.  In vitro activity of a new antifungal triazole, D0870, against Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus.  Antimicrob Agents Chemother 38:2553-2556.
  • Barchiese F, Colombo AL, McGough DA, Rinaldi MG.  1994.  Comparative study of broth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Committee for Clinical Laboratory Standards proposed standard. J Clin Microbiol 32:2494-2500.
  • Colombo AL, Barchiesi, McGough DA, Rinaldi MG.  1995.  Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing.  J Clin Microbiol 33:535-540.
  • Krisher KK, Holdridge NB, Mustafa MM, Rinaldi MG, McGough DA.  1995.  Disseminated Microascus cirrosus infection in a pediatric bone marrow transplant recipient.  J Clin Microbiol 33:735-737.
  • Barchiese F, Hollis RJ, McGough DA, Scalise G, Rinaldi MG, Pfaller MA.  1995.  DNA subtypes and fluconazole susceptibilities of Candida albicans isolates from oral cavities of patients with AIDS.  Clin Infect Dis 20:634-640.
  • Barchiesi F, Hollis RJ, Del Poeta M, McGough DA, Scalise G, Rinaldi MG, Pfaller MA.  1995.  Transmission of fluconazole resistant Candida albicans in patients with AIDS and oral candidiasis documented by pulsed field gel electrophoresis. Clin Infect Dis 21:561-564.
  • Abbott SP, Sigler L, McAleer R, McGough DA, Rinaldi MG, Mizell G.  1995.  Fatal cerebral mycoses caused by the ascomycete Chaetomium strumarium.  J Clin Microbiol 33:2692-2698.
  • Nguyen MH, Barchiesi F, McGough D, Yu VL, Rinaldi MG.  1995.  In vitro evaluation of combination of fluconazole and flucytosine against Cryptococcus neoformans  var. neoformans.  Antimicrob Agents Chemother 39:1691-1695.
  • Walsh TJ, Peter J, McGough DA, Fothergill AW, Rinaldi MG, PIzzo PA.  1995.  Activity of amphotericin B and antifungal azole alone and in combination against Pseudallescheria boydii.  Antimicrob Agents Chemother 39:1361-1364.
  • Colombo AL, Barchiese F, McGough DA, Fothergill AW, Rinaldi MG.  1995.  Evaluation of the Etest system versus a microtiter broth method for antifungal susceptibility testing of yeasts against fluconazole and itraconazole.  J Antimicrob Chemother 36:93-100.
  • Weitzman I, McGough DA, Rinaldi MG, Della-Latta P.  1996.  Rhizopus schipperae, sp. nov., a new agent of zygomycosis.  Mycotaxon 59:217-225.
  • Patterson TF, Revankar SG, Kirkpatrick WR, Dib O, Fothergill AW, Redding SW, Sutton DA, Rinaldi MG.  1996.  A simple method for detecting fluconazole resistant yeasts with chromogenic agar.  J Clin Microbiol 34:1794-1797.
  • Sigler Ll, Summerbell RC, Poole L, Wieden M, Sutton DA, Rinaldi MG, Stout, M, Estes GW, Galgiani JN.  1996.  Invasive Nattrassia mangiferae infections.  Case report, literature review, therapeutic and taxonomic appraisal.  J Clin Microbiol 35:433-440.
  • Sutton DA, Padhye AA, Standard PG, Rinaldi MG.  1997.  An aberrant variant of Histoplasma capsulatum var. capsulatum.  J Clin Microbiol 35:734-735.
  • McGinnis MR, Pasarell L, Sutton DA, Fothergill AW, Cooper CR Jr, Rinaldi MG.  1997.  In vitro evaluation of voriconazole against some clinically important fungi.  Antimicrob Agents Chemother 41:1832-1834.
  • Furukawa H, Kusen S, Sutton DA, Manez R, Carrau R, Nichols L, Abu-Elmagd K, Skedros D, Todo S, Rinaldi MG.  1998.  Acute invasive sinusitis due to Trichoderma longibrachiatum in a liver and small bowel transplant recipient.  Clin Inf Dis 26:487-489.
  • Nguyen MH, Clancy CJ, Yu VL, Yu YC, Morris AJ, Syndman Dr, Sutton DA, Rinaldi MG.  1998.  Do in vitro susceptibility data predict the microbiologic response to amphotericin B?  Results of a prespective study of patients with Candida fungemia.  J Infect Dis 177:425-430.
  • Sutton DA, Slifkin M, Yakulis R, Rinaldi MG.  1998.  A U.S. case report of Ramichloridium obovoideum (R. mackenziei) cerebral phaeohyphomycosis: criteria for identification, therapy, and a review of other known dematiaceous neurotropic taxa.  J Clin Microbiol 36:708-715.
  • Shin JH, Lee SK, Suh SP, Ryang DW, Kim NH, Rinaldi MG, Sutton DA.  1998.  Fatal Hormonema dematioides peritonitis in a patient on CAPD: criteria for identification and a review of other known fungal etiologics agents.  J Clin Microbiol 36:2157-2163.
  • McGinnis MR, Pasarell L, Sutton DA, Fothergill AW, Cooper CR Jr, Rinaldi MG.  1998.  In vitro activity of voriconazole against selected fungi.  Med Mycol 36:239-242.
  • Sutton DA, Timm WD, Morgan-Jones G, Rinaldi MG.  1999.  Human phaeohyphomycotic osteomyelitis caused by the coelomycete Phomopsis Saccardo 1905: criteria for identification, case history, and therapy.  J Clin Microbiol 37:807-811.
  • Iwen PC, Rupp ME, Bishop MR, Tarantolo S, Hinrichs S, Rinaldi MG, Sutton DA.  1998.  Disseminated aspergillosis caused by Aspergillus ustus in a patient following allogeneic peripheral stem cell transplantation.  J Clin Microbiol 36:3713-3717.
  • Revankar SG, Sutton DA, Sanche SE, Rao J, Zervos M, Dashti, Rinaldi MG.  1999.  Metarrhizium anisopliae as a cause of sinusitis in immunocompetent hosts.  J Clin Microbiol 37:195-198.
  • Anstead GM, Sutton DA, Thompson EH, Weitzman I, Otto RA, Ahuja S.  1999.  Campylobacter jejuni bacteremia and disseminated zygomycosis due to Rhizopus schipperae after heatstroke.  J Clin Microbiol 37:2656-2662. 
  • Richter S, Cormican MG, Pfaller MA, Lee CK, Gingrich R, Rinaldi MG, Sutton DA.  1999.  Fatal disseminated Trichoderma longibrachiatum infection in an adult bone marrow transplant patient: species identification and view of the literature.  J Clin Microbiol 37:1154-1160.
  • Sutton DA, Fothergill AW, Rinaldi MG.  1999.  Ramichloridium obovoideum (R. mackenziei) and other dematiaceous neurotropic fungi.  Tech Sample Microbiology No MB-4, Amer Soc Clin Path.
  • Sutton DA, Sanche SE, Revankar SG, Fothergill AW, Rinaldi MG.  1999.  In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head to head comparison to voriconazole.  J Clin Microbiol 37:2343-2345.
  • Sutton DA.  1999.  Coelomycetous fungi in human disease.  A review: clinical entities, pathogenesis, identification, and therapy.  Rev Iberoam Mycol 16:171-179.
  • Iwen PC, Tarantolo S, Sigler L, Sutton DA, Rinaldi MG, Lackner RP, McCarthy DI, Hinrichs SH.  2000.  Pulmonary infection caused by Gymnascella hyalinospora in a patient with acute myelogenous leukemia.  J Clin Microbiol 38:375-381.
  • Baddley JW, Moser SA, Sutton DA, Pappas PG.  2000.  Microascus cinereus brain abscess in a bone marrow transplant recipient J Clin Microbiol 38:395-397.
  • Khan ZU, Kortom M, Marouf R, Chandy R, Rinaldi MG, Sutton DA.  2000.  Bilateral pulmonary aspergilloma caused by an atypical isolate of Aspergillus terreus.  J Clin Microbiol 38:2010-2014.
  • Al-Mohsen IZ, Sutton DA, Sigler L, Almodovar E, Mahgoub N, Frayha H, Al-Hajjaar S, Rinaldi MG, Walsh TJ.  2000.  Acrophialophora fusispora brain abscess in  a child with acute lymphoblastic leukemia.  Case history, clinical course, and literature review.  J Clin Microbiol 38:4569-4576.
  • Iwen PC, Tarantolo SR, Sutton DA, Rinaldi MG, Hinricks SH.  2000.  Cylindrocarpon lichenicola in a patient with acute myelogenous leukemia.  J Clin Microbiol 38:3375-3378.
  • Perea S, Pennick GJ, Modak A, Fothergill AW, Sutton DA, Sheehan DJ, Rinaldi MG.  2000.  Comparison of high-performance liquid chromatographic and microbiological methods for determination of voriconazole levels in plasma.  Antimicrob Agents Chemother 44:1209-1213.
  • Hart AP, Sutton DA, McFeeley PJ, Kornfeld M.  2001.  Cerebral phaeohyphomycosis caused by a dematiaceous Scopulariopsis species.  Clin Neuropathol 20:224-228.
  • Chin-Hong PV, Sutton DA, Roemer M, Jacobson MA, Aberg JA.  2001.  Invasive fungal sinusitis and meningitis due to Arthrographis kalrae in a patient with AIDS.  J Clin Microbiol 39:804-807.
  • Perea S, Fothergill AW, Sutton DA, Rinaldi MG.  2001.  Comparison of the in vitro activity of voriconazole with five established antifungal agents against different species of dermatophytes using a broth macrodilution method.  J Clin Microbiol 39:385-388.
  • Gonzales GM, Sutton DA, Thompson E, Tijerina R, Rinaldi MG.  2001.  In vitro activity of approved and investigational antifunal agents against 44 clinical isolates of basidiomycetous fungi.  Antimicrob Agents Chemother 45:633-635.
  • Nucci M, Revankar SG, Sutton D, Patterson TF.  2001.  Nosocomial fungemia due to Exophiala jeanselmei variety jeanselmei and a Rhinocladiella species: newly described causes of blood stream infection.  J Clin Microbiol 39:514-518.
  • Korzets A, Weinberger M, Chagnac A, Goldschmied-Reouven A, Rinaldi MG, Sutton DA.  2001.  Peritonitis due to Thermoascus taitungiacus (anamorph Paecilomyces taitungiacus).  J Clin Microbiol 39:720-724.
  • Perea S, Gonzalez G, Fothergill AW, Sutton DA, Rinaldi MG.  2002.  In vitro interaction of terbinafine with fluconazole, itraconazole, voriconazole and posaconazole against clinical isolates of Candida glabrata with dedreased susceptibility to azoles.  J Clin Microbiol 40:1831-1833.
  • Gonzalez GM, Tijerina R, Sutton DA, Graybill JR, Rinaldi MG.  2002.  In vitro activity of the free and lipid formulations of amphotericin B and nystatin against clinical isolates of Coccidioides immitis in various saprobic stages.  Antimicrob Agents Chemother 46:1583-1585.
  • Revankar SG, Patterson JE, Sutton DA, Pullen R, Rinaldi MG.  2002.  Disseminated phaeohyphomycosis: review of an emerging mycosis.  Clin Infect Dis 34:467-476.
  • Sutton DA.  2002.  Cylindrocarpon lichenicola, a Fusarium look-alike: its ecology identification, and etiologic potential.  Microbiology Tech Sample. Amer Soc Clin Pathol No:MB-6(2002), p 7-10.
  • Nucci M, Akiti T, Barreiros B, Silveira F, Revankar SG, Wickes BL, Sutton DA, Patterson TF.  2002.  Nosocomial outbreak of Exophiala jeanselmei fungemia associated with contamination of hospital water.  Clin Infect Dis 34:1475-1480.
  • Gavin PJ, Sutton DA, Katz BZ.  2002.  Fatal endocarditis in a neonate caused by the dematiaceous fungus Phialemonium obovatum: a case report and review of the literature. J Clin Microbiol 40:2207-2212.
  • Castiglioni B, Sutton DA, Rinaldi MG, Fung J, Kusne S.  2002.  Pseudallescheria boydii (anamorph Scedosporium apiospermum) infection in solid organ transplant recipients in a tertiary medical center and review of the literature.  Medicine 81:333-348.
  • Yildiran ST, Fothergill AW, Sutton DA, Rinaldi MG.  2002.  In vitro susceptibilities of cerebrospinal fluid isolates of Cryptococcus neoformans collected during a ten-year period against fluconazole and posaconazole (SCH 56592).  Mycoses 45:378-383.
  • Revankar SG, Patterson J, Sutton DA, Rinaldi MG.  2002.  Central venous catheter as a risk factor for disseminated phaeohyphomycosis?  Reply.  Correspondence.  Clin Infect Dis 35:1023-1024.
  • Sutton DA.  2002.  Laboratory evaluation of new antifungal agents against rare and refractory mycoses.  Curr Opin Infect Dis 15:575-582.
  • Manire CA, Rhinehart HL, Sutton DA, Thompson EH, Rinaldi MG, Buch JD, Jacobson E.  2002.  Disseminated mycotic infection caused by Colletotrichum acutatum in a Kemp’s Ridley sea turtle, Lepidochelys kempi.  J Clin Microbiol 40:4273-4280.
  • Hepburn MJ, Pennick GJ, Sutton DA, Crawford G, Jorgensen JH.  2003.  Candida krusei renal cyst infection and measurement of amphotericin B level in cystic fluid in a patient receiving AmBisome®.  Med Mycol 41:163-165.
  • Manire CA, Rhinehart HL, Pennick GJ, Sutton DA, Hunter R, Rinaldi MG.  2003.  Steady-state pharmacokinetics and tissue concentrations of itraconazole following oral administration in sea turtles.  J Zoo and Wildlife Med 34:171-178.
  • Pennick GJ, Clark M, Sutton DA, Rinaldi MG.  2003.  Development and validation of an HPLC voriconazole assay.  Antimicrob Agents Chemother 47:2348-2350.
  • Walsh TJ, Petraitis V, Petraitiene R, Field-Ridley A, Sutton DA, Ghannoum M, Sein T, Schaufele R, Peter J, Bacher J, Casler H, Armstrong D, Espinel-Ingroff A, Rinaldi MG, Lyman CA.  2003.  Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B. J Infect Dis 188:305-319.
  • Porteus NB, Redding SW, Thompson EH, Grooters AM, de Hoog GS, Sutton DA.  2003.  Isolation of an unusual fungus in treated dental unit waterlines.  J Amer Dental Assoc 134:853-858.
  • Solé MJ, Cano JL, Rodríquez-Tudela, Pontón J, Sutton DA, Ellis MG, Guarro J.  2003.  Molecular typing of clinical and environmental isolates of Scedosporium prolificans by inter-single-sequence-repeat-PCR.  Med Mycol 41:293-300.
  • Porteus NB, Grooters AM, Redding SW, Thompson EH, Rinaldi MG, de Hoog GS, Sutton DA.  2003.  Identification of Exophiala mesophila isolated from dental unit waterlines.  J Clin Microbiol 41:3885-3889.
  • Barron MA, Sutton DA, Veve R, Guarro J, Rinaldi M, Thompson E, Cagnoni PJ, Moultney-Hilt K, Madinger NE.  2003.  Invasive mycotic infections caused by Chaetomium perlucidum: a new agent of human disease.  J Clin Microbiol 41:5302-5307.
  • Bossler AD, Richter SS, Chavez AJ, Vogelgesang SA, Sutton DA, Grooters AM, Rinaldi MG, de Hoog GS, Pfaller MA.  2003.  Exophiala oligosperma causing olecranon bursitis.  J Clin Microbiol 41:4779-4782.
  • Carey J, D’Amico R, Sutton DA, Rinaldi MG.  2003.  Paecilomyces lilacinus vaginitis in an immunocompetent patient.  Emerg Infect Dis 9:(1155-1158).  Available from: URL:
  • Serena C, Ortoneda M, Capilla J, Pastor FJ, Sutton DA, Rinaldi MG, Guarro J.  2003.  In vitro activity of new antifungal agents against Chaetomium spp. and inoculum standardization.  Antimicrob Agents Chemother 47:3161-3164.
  • Revankar SG, Sutton DA, Rinaldi MG.  2004.  Primary central nervous system phaeohyphomycosis: a review of 101 cases. Clin Infect Dis 38:206-216.
  • Proia LA, Hayden MK, Kammeyer PL, Ortiz J, Sutton DA, Clark T, Schroers H-J, Summergell RC.  2004  Phialemonium, an emerging mould pathogen causing four cases of hemodialysis-assiciated endovascular infection.  C Infect Dis 39:373-379.
  • Sutton DA, Rinaldi MG, Kielhofner M.  2004.  First U.S. report of subcutaneous
    phaeohyphomycosis caused by Veronaea botyryosa in a heart transplant recipient and review of the literature.  J Clin Microbiol 42:2843-2846.
  • Yoder BA, Sutton Da, Winter V, Coalson JJ. 2004.  Resistant Candida parapsilosis associated with long-term fluconazole prophylaxis.  Ped Infect Dis J 23:687-688.
  • O’Donnell K, Sutton DA, Rinaldi MG, Magnon KC, Cox PA, Revankar SJ, Sanche S, Geiser
    DM, Juba JH, van Burik JH, Padhye A, Robinson JS. 2004.  Genetic diversity of human pathogenic   members of the Fusarium oxysporum complex inferred from gene genealogies and AFLP analyses: evidence for the recent dispersion of a geographically widespread clone and nosocomial origin.  J Clin Microbiol 42:5109-5120.
  • Odds FC, Motyl M, Andrade R, Bille J, Cantón E, Cuenca-Estrella M, Davidson A, Durussel C, Ellis D, Foraker E. Fothergill AW, Ghannoum MA, Giacobbe RA, Gobernado M, Handke R, Laverdière M, Lee-Yang W, Merz WG, Ostrosky-Zeichner L, Pemán J, Perea S, Perfect JR, Pfaller MA, Proia L, Rex JH, Rinaldi MG, Rodriguez-Tudela J-L, Schell WA, Chields C, Sutton DA, Verweij PE, and Warnock DW.  2004.  Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species.  J Clin Microbiol 42:3475-3482.
  • Al-Abdely HM, Alkhunaizi A, Al-Tawfio J, Hassonah M, Rinaldi MG, Sutton DA.  2004. Successful therapy of cerebral phaeohyphomycosis due to Ramichloridium mackenziei with the new triazole posaconazole.  Med Mycol 43:91-95.
  • Sutton DA, Thompson EH, Rinaldi MG, Iwen PC, Nakasone KK, Jung HS, Rosenblatt HM, Paul ME.  2004.  Identification and first report of Inonotus (=Phellinus) tropicalis as an etiologic agent in a patient with chronic granulomatous disease. J Clin Microbiol 43:982-987.
  • Mostert L, Groenewald JZ, Summerbell RC, Robert V, Sutton DA, Padhye AA, Crous PW.  2004.  Species of Phaeoacremonium associated with human infections and environmental reservoirs in infected woody plants.  J Clin Microbiol 43:1752-1767.
  • Nielsen C, Sutton DA, Matise I, Kirchhof N, Polzin D, Libal MC.  2005.  Isolation of   
    Cokeromyces recurvatus, initially misidentified as Coccidioides immitis, from peritoneal fluid in a cat with    jejunal perforation. J Vet Diag Invest 17:372-378.
  • González GM, Fothergill AW, Sutton DA, Rinaldi MG, Loebengerg D.  2005.  In vitro activities of new and established triazoles against opportunistic filamentous and dimorphic fungi.  Med Mycol 43:281-284.
  • Scott RS, Sutton DA, Jagirdar J.  2005.  Lung infection due to opportunistic fungus, Phialemonium obovatum, in a bone marrow transplant recipient: an emerging infection with fungemia and Crohn disease-like involvement of the gastrointestinal tract.  Annals of Diag Pathol 9:227-230.
  • Singh K, Flood J, Welsh RD, Wyckoff III JH, Sutton DA. 2006. Fatal systemic phaeohyphomycosis caused by Ochroconis gallopava in a dog (Canis familaris). Vet Pathology 43:988-992.
  • Weinberger M, Mahrshak I, Keller N, Goldschmied-Reuven, Amariglio N, Kramer M, Tobar A, Samra Z, Pitlik SD, Rinaldi MG, Thompson E, Sutton D.  2006.  Isolated endogenous endophthalmitis due to a sporodochial-forming Phialemonium curvatum acquired through intracavernous penile injection.  Medical Mycology 44:253-259.
  • deHoog GS, Zeng JS, Harrak MJ, Sutton DA.  2006.  Exophiala xenobiotica sp. nov., an opportunistic black yeast inhabiting environments rich in hydrocarbons.  Antonie van Leeuwenhoek 90:257-268.
  • Yildiran ST, Mutlu FM, Saracli MA, Uysal Y, Gönlüm. Spbaco G. Sutton DA.  2006.  Fungal endophthalmitis caused by Aspergillus ustus in a patient following cataract surgery.  Medical Mycology 44:665-669.
  • Maskit B-M, Sutton DA, Wickes B, Kurtzman CP, Goldman S, Zheng X. 2006.  Catheter-related fungemia due to Candida thermophila.  J Clin Microbiol 44:3035-3036.
  • Zhang N, O’Donnell K, Sutton DA, Nalim FA, Summerbell RC, Padhye AA, Geiser DM.  2006.  Members of the Fusarium solani species complex that cause infections in both humand and plants are common in the environment.  J Clin Microbiol 44:2186-2190.
  • Pfaller MA, Sutton DA.  2006.  Review of in vitro activity of sertaconazole nitrate in the treatment of superficial fungal infections.  Diag Microbiol Infect Dis 56:147-152.
  • Dan M, Yossepowitch O, Hendel D, Shwartz O, Sutton DA.  2006.  Phialemonium curvatum arthritis of the knee following intra-articular injection of a corticosteroid.  Medical Mycology. 44:571-574
  • Almyroudis NG, Sutton DA, Linden P, Rinaldi MG, Fung J, Kusne S.  2006.  Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature.  Amer J Transplantation  10:2365-2374.
  • Antachopoulos C, Meletiadis J, Rolides E, Sein T, Sutton DA, Wickes BL, Rinaldi MG, Merz WG, Shea YR,  Walsh TJ.  2006.  Relationship between metabolism and biomass of medically important zygomycetes.  Medical Mycology 44:429-438.
  • Destino L, Sutton DA, Helon AL, Haven PL, Thometz JG, Willoughby R, Chusid MJ.  2006.  Severe osteomyelitis caused by Myceliophthora thermophila after a pitchfork injury.  Annals of Clin Microbiol and Antimicrob. 5:21;
  • Fothergill AW, Rinaldi MG, Sutton DA.  2006.  Antifungal susceptibility testing.  Inf Dis Clin North Am 20:699-709.
  • Van Schooneveld T, Freifeld A, Lesiak B, Kalil A, Sutton DA, Iwen PC.  2007.  Paecilomyces lilacinus infection in a liver transplant patient: case report and review of the literature. Transplant Infect Diseases, Published Online 1-Jul-2007, doi:10.1111/j.1339-3062.2007.00248.x
  • Saracli MA, Mutlu FM, Yildiran ST, Kurekci AE, Gonlum A, Uysal Y, Erden U, Basustaoglu AC, Sutton DA. 2007.  Clustering of invasive Aspergillus ustus eye infections in a tertiary care hospital:  A molecular epidemiologic study.  Med Mycol 45:377-384.
  • O’Donnell K, Sarver B, Brandt M, Chang DC, Nobel-Wang J, Rao CY, Park BJ, Sutton DA, Benjamin L, Padhye A, Geiser DV, Ward TJ. 2007.  Phylogenetic diversity and microsphere array-based genotyping of human pathogenic fusaria, focusing on the 2005-06 multistate dermatitis outbreaks among soft contact lens wearers within the U.S.  J Clin Microbiol 45: 2235-2248.
  • Almyroudis NG, Sutton DA, Fothergill AW, Rinaldi MG, Kusne S.  In vitro susceptibilities of 217 clinical isolates of zygomycetes.  2007.  Antimicrob Agents Chemother. 51:2587-2590.
  • Davis CM, Noroski LM, Dishop MK, Sutton DA, Braverman RM, Paul ME, Rosenblatt HM. 2007.  Basidiomycetous fungal Inonotus tropicalis sacral osteomyelitis in X-linted chronic granulomatous disease.  The Ped Infect Dis J 26: 655-656.
  • Zeng JS, Sutton DA, Fothergill AW, Rinaldi MG, Harrak MJ, de Hoog GS.  2007
    Spectrum of clinically relevant Exophiala species in the U.S.A. J Clin Microbiol 45:3713-3720.
  • Marimon R, Cano J, Gené J, Sutton DA, Kawasaki, Guarro J.  2007.  Three new Sporothrix species  of clinical interest: S. brasiliensis, S. globosa, and S. mexicana. J Clin Microbiol 45:3198-3206.
  • Sutton DA.  Diagnosis of coccidioidomycosis by culture.  Safety considerations, traditional methods and susceptibility testing.  2007.   Ann N Y Acad Sci 1111:305-325.
  • Sutton DA, Wickes BL, Thompson EH, Rinaldi MG, Roland RM, Libal MC, Russell K, Gordon S. 2007. Pulmonary Phialemonium curvatum phaeohyphomycosis in a Standard Poodle dog.  Med Mycol, Accepted 12-12-07.
  • Cortez KJ, Roilides E. Quiroz-Telles F, Meletiadis J,  Antachopoulos C, Knudsen R, Buchanan W, Milanovich J, Sutton DA, Fothergill A, Rinaldi MG, Shea YR, Zaoutis T, -Kottilil S, Walsh TJ.  2008.  Infections caused by Scedosporium spp.  Clin Microbiol Rev 21:157-197.
Health Science Center seal

Links provided from Health Science Center pages to other web sites do not constitute or imply an endorsement of those sites, their content, or products and services associated with those sites.
Best viewed at 1024x768 resolution.